6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Neurocognitive Therapy for Substance Use Disorders
Neurocognitive therapy is a therapeutic approach that addresses cognitive deficits commonly seen in individuals with substance use disorders. These deficits, such as problems with memory, attention, and executive function, often result from the chronic use of substances. Neurocognitive therapy aims to restore and enhance cognitive functioning through various exercises and techniques that promote brain plasticity. It may include cognitive retraining, memory exercises, and problem-solving tasks. By improving cognitive abilities, patients are better equipped to handle the challenges of addiction recovery, make informed decisions, and maintain long-term sobriety. This approach plays a key role in addressing the cognitive aspects of addiction and recovery.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Michelle Charbonnier
MoNetwork, United States
Monica Zuniga Fajuri
Tiburcio Vasquez Health Center, United StatesSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States